Conference abstractPublished 20 Mar 2019
Plasmonic nanostructures for imaging and targeting drug delivery
Rice University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Engineering a compact, near-infrared plasmonic nanostructure with integrated image-enhancing agents for combined imaging and therapy is an important nanomedical challenge. To overcome this challenge we designed a nanostructure with NIR plasmonic signatures composed of a 50nm Au core surrounded a SiO2 inner-shell doped with contrast agents and an outer Au shell. The plasmon resonance of this nanostructure, known as a nanomatryoshka (NM), can be tuned to the desired wavelength by varying the thickness of the layers. The encapsulated contrast agents used in this study are: Fe(III)-DOTA, Gd(III)-DOTA, and fluorescent dyes. The Fe(III)-NM based contrast agents are found to have relaxivities two times greater than the widely used Gd(III)-DOTA, providing a practical alternative for T1 MRI contrast agent that eliminates Gd(III) patient exposure entirely. Additionally, the internalization of fluorescent dyes and MRI contrast imaging agents within the NM substantially reduces the toxicity while maintaining a free nanoparticles surface for further bio-functionalization.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- SubjectNanotechnology
- SubjectRadiology & Imaging
- BylineArticles whose byline prints “Oara Neumann”
